Summary & Overview
HCPCS Level II Q4391: Amnioplast double, per square centimeter
HCPCS Level II code Q4391 denotes a double-layer amnioplastic graft billed per square centimeter as an add-on to a primary surgical procedure. This code matters nationally because it standardizes reporting for the application of amniotic membrane products in surgical and wound-care settings, enabling clearer tracking of utilization and facilitating consistent claims processing for adjunct biologic graft materials. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what the code represents clinically and operationally, the typical sites of service where it is used (operating room, ambulatory surgical center, procedure suite), and what to expect in terms of payor coverage considerations. The publication provides benchmarks and coding context for billed surface area units, describes common modifiers and their billing roles, and summarizes national policy themes affecting add-on biologic graft codes. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4391 describes Amnioplast double, billed per square centimeter as an add-on, list separately in addition to primary procedure. This code represents the application of a double-layer amniotic membrane graft product measured and billed by surface area.
-
Service type: Surgical grafting/tissue augmentation using an amniotic membrane product
-
Typical site of service: Operating room or procedure suite in a hospital or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or adolescent presenting with a full-thickness or complex amniotic membrane defect after conjunctival disease, ocular surface reconstruction, pterygium surgery complication, chemical burn, or persistent corneal epithelial defect. The procedure coded as Q4391 (amnioplast double, per square centimeter) is used when two layers of amniotic membrane are applied to the ocular surface to promote healing, provide a biologic scaffold, reduce inflammation, and restore corneal or conjunctival integrity. Clinical workflow includes preoperative assessment by an ophthalmologist (cornea or oculoplastic specialist), informed consent, sterile preparation in an operating room or procedure suite, measurement of the defect size, tailoring and securing two layers of amniotic membrane (often with fibrin glue, sutures, or a combination), postoperative topical antibiotics and corticosteroids, and scheduled follow-up visits to monitor integration and epithelialization. Typical sites of service are hospital outpatient surgical departments, ambulatory surgery centers, and certain ophthalmology procedure suites equipped for minor ocular surgery. Patient factors such as active infection, ocular surface inflammation, and prior grafting procedures influence intraoperative decisions and potential use of modifiers to reflect complexity or supplies used.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting |